221 related articles for article (PubMed ID: 26790404)
1. The ratio of skeletal muscle mass to visceral fat area is a main determinant linking circulating irisin to metabolic phenotype.
Hwang YC; Jeon WS; Park CY; Youn BS
Cardiovasc Diabetol; 2016 Jan; 15():9. PubMed ID: 26790404
[TBL] [Abstract][Full Text] [Related]
2. Association of serum C1q/TNF-Related Protein-9 (CTRP9) concentration with visceral adiposity and metabolic syndrome in humans.
Hwang YC; Woo Oh S; Park SW; Park CY
Int J Obes (Lond); 2014 Sep; 38(9):1207-12. PubMed ID: 24357853
[TBL] [Abstract][Full Text] [Related]
3. Association of circulating irisin levels with metabolic and metabolite profiles of Korean adolescents.
Jang HB; Kim HJ; Kang JH; Park SI; Park KH; Lee HJ
Metabolism; 2017 Aug; 73():100-108. PubMed ID: 28732566
[TBL] [Abstract][Full Text] [Related]
4. Association between skeletal muscle mass to visceral fat area ratio and arterial stiffness in Chinese patients with type 2 diabetes mellitus.
Xu J; Pan X; Liang H; Lin Y; Hong Y; Si Q; Shen F; Gu X
BMC Cardiovasc Disord; 2018 May; 18(1):89. PubMed ID: 29739314
[TBL] [Abstract][Full Text] [Related]
5. Increased irisin versus reduced fibroblast growth factor1 (FGF1) in relation to adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and without prediabetes.
Saber GY; Kasabri V; Saleh MI; Suyagh M; Halaseh L; Jaber R; Abu-Hassan H; Alalawi S
Horm Mol Biol Clin Investig; 2019 Mar; 38(1):. PubMed ID: 30840586
[TBL] [Abstract][Full Text] [Related]
6. The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity.
Komosinska-Vassev K; Gala O; Olczyk K; Jura-Półtorak A; Olczyk P
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32917052
[TBL] [Abstract][Full Text] [Related]
7. Obese with higher FNDC5/Irisin levels have a better metabolic profile, lower lipopolysaccharide levels and type 2 diabetes risk.
Bonfante ILP; Chacon-Mikahil MPT; Brunelli DT; Gáspari AF; Duft RG; Oliveira AG; Araujo TG; Saad MJA; Cavaglieri CR
Arch Endocrinol Metab; 2017 Dec; 61(6):524-533. PubMed ID: 29412381
[TBL] [Abstract][Full Text] [Related]
8. Decreased irisin secretion contributes to muscle insulin resistance in high-fat diet mice.
Yang Z; Chen X; Chen Y; Zhao Q
Int J Clin Exp Pathol; 2015; 8(6):6490-7. PubMed ID: 26261526
[TBL] [Abstract][Full Text] [Related]
9. The association of circulating irisin with metabolic risk factors in Chinese adults: a cross-sectional community-based study.
Tang L; Tong Y; Zhang F; Chen G; Zhang YC; Jobin J; Tong N
BMC Endocr Disord; 2019 Dec; 19(1):147. PubMed ID: 31881940
[TBL] [Abstract][Full Text] [Related]
10. Circulating irisin levels reflect visceral adiposity in non-diabetic patients undergoing hemodialysis.
Yilmaz H; Cakmak M; Darcin T; Inan O; Sahiner E; Demir C; Aktas A; Bilgic MA; Akcay A
Ren Fail; 2016 Jul; 38(6):914-9. PubMed ID: 27089215
[TBL] [Abstract][Full Text] [Related]
11. Associations of circulating irisin with 24-h blood pressure, total and visceral fat, and metabolic parameters in young adult hypertensives.
Miazgowski T; Miazgowski B; Kaczmarkiewicz A; Kopeć J
Arch Endocrinol Metab; 2021 Nov; 65(2):137-143. PubMed ID: 33905629
[TBL] [Abstract][Full Text] [Related]
12. Irisin is more strongly predicted by muscle oxidative potential than adiposity in non-diabetic men.
Huth C; Dubois MJ; Marette A; Tremblay A; Weisnagel SJ; Lacaille M; Mauriège P; Joanisse DR
J Physiol Biochem; 2015 Sep; 71(3):559-68. PubMed ID: 25820475
[TBL] [Abstract][Full Text] [Related]
13. A case-control study to evaluate irisin levels in patients with type 1 diabetes mellitus.
Abdulabbas DA; Hassan EA
Ir J Med Sci; 2024 Jun; 193(3):1275-1282. PubMed ID: 38349510
[TBL] [Abstract][Full Text] [Related]
14. Circulating serum irisin levels in obesity and type 2 diabetes mellitus.
Shoukry A; Shalaby SM; El-Arabi Bdeer S; Mahmoud AA; Mousa MM; Khalifa A
IUBMB Life; 2016 Jul; 68(7):544-56. PubMed ID: 27220658
[TBL] [Abstract][Full Text] [Related]
15. Relationship Between Serum Macrophage Migration Inhibitory Factor Level and Insulin Resistance, High-Sensitivity C-Reactive Protein and Visceral Fat Mass in Prediabetes.
Bilgir O; Gökçen B; Bilgir F; Guler A; Calan M; Yuksel A; Aslanıpour B; Akşit M; Bozkaya G
Am J Med Sci; 2018 Jan; 355(1):37-43. PubMed ID: 29289260
[TBL] [Abstract][Full Text] [Related]
16. Association between visceral adipose tissue volume, measured using computed tomography, and cardio-metabolic risk factors.
Yi W; Kim K; Im M; Ryang S; Kim EH; Kim M; Jeon YK; Kim SS; Kim BH; Pak K; Kim IJ; Kim SJ
Sci Rep; 2022 Jan; 12(1):387. PubMed ID: 35013484
[TBL] [Abstract][Full Text] [Related]
17. Circulating irisin in relation to insulin resistance and the metabolic syndrome.
Park KH; Zaichenko L; Brinkoetter M; Thakkar B; Sahin-Efe A; Joung KE; Tsoukas MA; Geladari EV; Huh JY; Dincer F; Davis CR; Crowell JA; Mantzoros CS
J Clin Endocrinol Metab; 2013 Dec; 98(12):4899-907. PubMed ID: 24057291
[TBL] [Abstract][Full Text] [Related]
18. Irisin is a predictor of sarcopenic obesity in type 2 diabetes mellitus: A cross-sectional study.
Oguz A; Sahin M; Tuzun D; Kurutas EB; Ulgen C; Bozkus O; Gul K
Medicine (Baltimore); 2021 Jul; 100(26):e26529. PubMed ID: 34190188
[TBL] [Abstract][Full Text] [Related]
19. Serum irisin levels in new-onset type 2 diabetes.
Choi YK; Kim MK; Bae KH; Seo HA; Jeong JY; Lee WK; Kim JG; Lee IK; Park KG
Diabetes Res Clin Pract; 2013 Apr; 100(1):96-101. PubMed ID: 23369227
[TBL] [Abstract][Full Text] [Related]
20. Elevated circulating irisin is associated with lower risk of insulin resistance: association and path analyses of obese Chinese adults.
Shi X; Lin M; Liu C; Xiao F; Liu Y; Huang P; Zeng X; Yan B; Liu S; Li X; Yang S; Li X; Li Z
BMC Endocr Disord; 2016 Jul; 16(1):44. PubMed ID: 27473122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
